Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Proponent Nasal Spray is a medical device developed by PRECLIN Biosystems AG for the treatment of unspecific nasal discomfort, including symptoms like dryness, irritation, and congestion. The spray's primary active component is ectoine, a natural extremolyte that forms a stable water layer known as the Ectoin-Hydro-Complex on the nasal mucosa. This layer acts as a physical barrier that stabilizes cell membranes and protects the underlying tissue from allergens and other environmental stressors. By facilitating the regeneration of the nasal epithelium and reducing inflammation through physical means, Proponent Nasal Spray provides immediate symptom relief. It has been evaluated in open-label observational studies to confirm its efficacy and safety in adult patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Proponent Nasal Spray.